Browsing: outperforms
Tirsepatide outperforms insulin in controlling diabetes and promoting weight loss in clinical trials
Supported by a meta-analysis of more than 4,300 patients, once-weekly tirzepatide reduces blood sugar, weight and cardiovascular risks more effectively…
In a recent study published in the journal Nature Medicinea large group of researchers in the United States discussed the…
The combination of the antibody amivantamab and lazertinib, a drug that targets EGFR, shows better clinical benefits compared with standard…